The roles below are to support an exciting new therapy for the treatment of Major Depressive Disorder (MDD) in adult patients. This treatment has “fast track” approval from the FDA and has the potential to treat people with MDD safely, effectively, more quickly and with greater tolerability than has previously been thought possible. The program has 3 phase III studies and an open label extension study. Learn more about any of them by clicking on the job specific links below or contact us directly with any questions you have!